Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline (Q37403069)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 February 2009
edit
Language Label Description Also known as
English
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
scientific article published on 26 February 2009

    Statements

    Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline (English)
    Barnett S Kramer
    Karen L Hagerty
    Stewart Justman
    Mark R Somerfield
    Peter C Albertsen
    William J Blot
    Joseph P Costantino
    Paul A Godley
    Russell P Harris
    Timothy J Wilt
    Robin Zon
    Paul Schellhammer
    American Society of Clinical Oncology/American Urological Association
    26 February 2009
    1642-1657

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit